SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-031828
Filing Date
2019-08-13
Accepted
2019-08-13 16:37:37
Documents
3
Period of Report
2019-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvus-8k_20190813.htm 8-K 32952
2 EX-99.1 nvus-ex991_15.htm EX-99.1 200296
3 GRAPHIC g1ghlg0hsdq2000001.jpg GRAPHIC 4902
  Complete submission text file 0001564590-19-031828.txt   241389
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 191021200
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1